Towards the Development of Orally Active Antimicrobial Peptides With Distinctive Mode of Action
Grant number: DP120101963 | Funding period: 2012 - 2014
Completed
Abstract
This project aims to design and develop novel antibacterial compounds to address one of humankind's greatest health concerns, that of antibacterial resistance. These will be further modified to make them orally available, thus enhancing their therapeutic and clinical potential.